August 9, 2023 05:42 PM EDTUpdated August 10, 11:48 AM
R&D

Il­lu­mi­na slash­es out­look for 2023, two ex­ec­u­tives de­part

Jared Whitlock

Features Editor

Il­lu­mi­na, the world’s largest DNA se­quenc­ing com­pa­ny, cut its sales fore­cast for 2023 as de­mand slumped in Chi­na, and al­so an­nounced that two ex­ec­u­tives will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times